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Arrhythmogenic right ventricular cardiomyopathy (ARVC)
is a genetically determined heart muscle disease with a wide
spectrum of clinical manifestations, ranging from concealed
myocardial abnormalities to overt clinical disease with life-
threatening arrhythmias and/or ongoing heart failure.1
Owing to the heterogeneous nature of the disease and its
clinical manifestations, there is not a single criterion that
determines a deﬁnitive diagnosis; even histopathologic
ﬁndings such as ﬁbrofatty myocardial replacement, although
suggestive of the disease, could be a ﬁnal common pathway
of several types of myocardial injury. For these reasons a
multiparametric approach based on several criteria has been
adopted.2 Since the publication of the original Task Force
criteria in 1994, attempts have been made to improve their
sensitivity, leading to the release of the modiﬁed Task Force
criteria in 2010.3 In the last decade, advanced technologies
have emerged and ongoing efforts are still directed toward
improvement of diagnostic techniques, sensitivities, and
speciﬁcities, especially in the setting of the early stages of
the disease.4 We report a case of a patient with sustained
ventricular tachycardia (VT) originating from the right
ventricular outﬂow tract (RVOT) in whom electroanatomical
mapping (EAM) was the only technique able to identify
subtle myocardial structural abnormalities, leading to the
hypothesis of ARVC, subsequently conﬁrmed by geneticKEYWORDS Electroanatomical mapping; Arrhythmogenic right ventricular
tachycardia; Ventricular tachycardia; ARVC
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to identify criteria failed to diagnose the disease.
Case report
A 50-year-old woman with a family history of unspeciﬁed
cardiomyopathy in a second-degree relative, and no other
known cardiovascular risk factors, presented to the emer-
gency room for sudden onset of palpitations associated with
shortness of breath that occurred during mild physical
activity. Surface 12-lead electrocardiogram (ECG) showed
a monomorphic VT at 245 beats per minute with a left
bundle branch block morphology, V4 transition, and left
inferior axis (Figure 1A), consistent with an RVOT origin,
which was effectively treated with external cardioversion.
Sinus rhythm 12-lead ECG was normal (Figure 1B). Trans-
thoracic echocardiography was unremarkable and coronary
artery disease was ruled out by coronary angiography. A
cardiac magnetic resonance imaging (cMRI) was performed
showing normal biventricular thickness, volumes, and func-
tion. T1-weighted, T2-weighted, and contrast-enhanced
imaging did not demonstrate any abnormalities. The patient
refused treatment with antiarrhythmic drugs and underwent
electrophysiology study and ablation for presumed “idio-
pathic VT.” A right ventricle (RV) endocardial bipolar
voltage was created and showed normal voltage (41.5
mV).5 However, a localized area of endocardial unipolar
voltage abnormality (r5.5 mV)6 was noted in the RVOT
free wall, suggestive of a mid-myocardial/subepicardial
disease process (Figure 2A and B). Programmed ventricular
stimulation induced the clinical VT (Figure 2C). Entrainment
could not be performed, as the VT would terminate with any
pacing attempt. Endocardial activation mapping was earliest
at the RVOT free wall; however, it was diffuse and not pre-pen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Electroanatomical mapping is useful as a
diagnostic tool in arrhythmogenic right ventricular
cardiomyopathy (ARVC) in early stages of the
disease.
 Epicardial mapping is a tool for early stages of ARVC
limited to the epicardium.
 Genetic testing for cardiac diseases is used as
conﬁrmatory testing on uncommon manifestations
of ARVC.
Heart Rhythm Case Reports, Vol 2, No 6, November 2016470QRS. At this stage, a decision for an epicardial approach was
made owing to the high suspicion of an epicardial origin. An
abnormal epicardial area with late potentials and fractionated
signals was seen in the epicardium opposite the area ofFigure 1 A: Twelve-lead electrocardiogram (ECG) of the clinical ventricular ta
and V4 precordial transition consistent with a right ventricular outﬂow tract/anterio
the slow upstroke of the R wave (pseudo-delta wave), particularly evident in the infe
B: The postcardioversion sinus rhythm 12-lead ECG shows only minor repolarizati
to meet classic T wave changes that help establish the diagnosis of ARVC.abnormal endocardial unipolar signals (Figure 2D). The
overall voltage was normal. Catheter manipulation during
mapping in this area induced clinical VT and mid-diastolic
potentials were recorded. This area was targeted with radio-
frequency ablation, which resulted in early termination of the
VT (Figure 2E and F). Additional radiofrequency lesions
were then applied in the adjacent area, eliminating the late
potentials and fractionated signals (Figure 2E and F). After
epicardial ablation, VT could no longer be induced with
programmed electrical stimulation. Given the evidence of
sustained VT in the setting of RV epicardial scar and unspeciﬁed
familial history of cardiomyopathy, we decided to proceed with
genetic testing for desmosomal gene abnormalities, looking for a
major criterion because the patient fulﬁlled only 1 minor criterion
(sustained VT with left bundle branch block morphology and
inferior axis) for the diagnosis of ARVC according to the 2010
Task Force criteria.3 Genetic testing revealed a heterozygous
pathogenic variant in the plakophilin-2 gene (variant p.chycardia showing a left bundle branch block morphology, left inferior axis,
r right ventricular free wall origin. The wideness of the QRS (4140 ms) and
rior leads and in the left precordial leads, suggest a possible epicardial origin.
on abnormalities (inverted T wave in V1 and biphasic T wave in V2) that fail
Figure 2 Electroanatomical mapping of the right ventricle showing A: a complete normal endocardial bipolar voltage (modiﬁed right anterior oblique view)
and B: a small area of endocardial unipolar abnormality, consistent with mid-myocardial/subepicardial scar, on the anterior free wall (same view).C:A sustained
ventricular tachycardia (VT) with 250 ms cycle length, matching the clinical VT, was induced with programmed ventricular stimulation. D: Epicardial mapping
(same view) showed bipolar low-voltage areas (color range from blue to red) consistent with epicardial fat distribution; no bipolar abnormality was seen over the
endocardial unipolar abnormality, but in this area late potentials during sinus rhythm (D: black dots and E: green arrow) and mid-diastolic potentials during VT
(E: red arrow) were mapped and effectively targeted with radiofrequency (RF) with early VT termination and noninducibility at the consequent programmed
ventricular stimulation. F: The ﬁnal RF lesion set is shown.
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ARVC. The genetic abnormality was also found in her brother,
who has not experienced any arrhythmias and does not ﬁt
diagnostic criteria.7 After discussion with the patient, an
implantation of a subcutaneous deﬁbrillator was undertaken.Discussion
Diagnosis of ARVC is based on a well-deﬁned pool of
criteria that sought to identify the genetic and structural
abnormalities consequent to the disease with different
electrocardiographic and imaging modalities. The diagnosis
is documented whenever 2 major, 1 major and 2 minor, or 4
minor criteria are present.2,3 Nevertheless, diagnosis of
ARVC is still challenging owing to the suboptimal sensi-
tivity and speciﬁcity of the described criteria, especially in
the setting of early-stage disease, in which myocardial
abnormalities can be subtle and limited to the epicardium
and may remain undetected by currently available non-
invasive diagnostic techniques, including echocardiography
and cMRI.8,9 There is a general agreement about cMRI being
the gold standard for myocardial scar characterization, but in
the setting of VT of RV origin, MRI has been reported tounderestimate the presence of scar compared with EAM.10,11
Moreover, the small amount of scar limited to the epicardial
layer may explain the inability of MRI to identify the
presence of such a subtle but well-deﬁned substrate.
EAM may contribute to the diagnosis of ARVC, demon-
strating either low-voltage areas or the presence of fractio-
nated, split, and late potentials compatible with scar and slow
conduction pathways able to sustain reentrant arrhyth-
mias.12–15 However, because the disease process is known
to start from the epicardium and extend toward the endocar-
dium, the substrate may be limited to the epicardial surface
and the endocardial bipolar voltage characteristics may be
normal. However, it would be too aggressive to perform
epicardial voltage mapping for diagnostic purposes. It has
been shown that endocardial unipolar voltage could predict
the abnormalities in the epicardium and, as such, could be
used as an effective tool for predicting epicardial abnormal-
ities, as illustrated by this case, and guide clinicians to
selectively undertake epicardial mapping.6
According to the results of recent observations, EAM allows
the identiﬁcation of otherwise unrecognized myocardial struc-
tural abnormalities in a signiﬁcant proportion of patients with
apparently idiopathic ventricular arrhythmias.10,15 Distinguishing
Heart Rhythm Case Reports, Vol 2, No 6, November 2016472truly idiopathic VTs from those related to undetected cardio-
myopathies is of critical importance for risk stratiﬁcation and
management. Although patients with idiopathic VTs have an
excellent prognosis, optimal treatment of the underlying heart
disease and sudden cardiac death prevention is required among
patients with VTs associated with a cardiomyopathy, particularly
one with strong genetic linkage and manifest sustained
arrhythmias.
The intensity of investigations required to exclude structural
heart disease in patients with idiopathic ventricular arrhythmias is
still uncertain. EAM should be considered in the diagnostic
work-up of patients with sustained VT and negative
routine diagnostic work-up to allow the early identiﬁcation of
subtle structural myocardial abnormalities, which may otherwise
remain unrecognized. However, this should be done in a stepwise
manner, and an invasive mapping should only be performed
when noninvasive results are inconclusive and the diagnostic
dilemma remains. Of note, EAM, when undertaken, should be
performed carefully, ensuring good tissue contact aided by force
sensing information or direct visualization with intracardiac
echocardiogram. This case report highlights the utility of EAM
as a possible diagnostic tool. We believe this is of particular
necessity when VT originated from free wall RVOT sites and
peritricuspid valvular sites.Conclusion
The diagnosis of ARVC is challenging and its prevalence is
likely to be underestimated. As in this case, it can often bemissed
by both echocardiography and cMRI in its early stages.
Epicardial mapping can be challenging and may not be available
in some centers. However, this case report highlights the utility of
endocardial and epicardial voltage mapping in providing val-
uable information to establish the diagnosis and successful
treatment of arrhythmia—in particular, in patients without classic
sinus rhythm ECG ﬁndings and morphologic changes identiﬁed
on echo and cMRI. Although we believe that successful VT
ablation may be adequate to achieve suppression from VT, we
still implant implantable cardioverter-deﬁbrillators because iden-
tiﬁcation of underlying ARVC could be a risk for recurrent
arrhythmias and sudden cardiac death.References
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